Christopher Sherman, MD
Family Medicine · Sylvania, OHNPI 1871599555
Payments from drug & device makers
Across 203 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$671
- AbbVie$541
- Novo Nordisk$305
- AstraZeneca$248
- Johnson & Johnson$205
- Amarin Pharma, Inc.$171
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,194100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 46 | $671 |
| AbbVie(2 entities) | 29 | $541 |
| Novo Nordisk | 26 | $305 |
| AstraZeneca | 7 | $248 |
| Johnson & Johnson | 14 | $205 |
| Amarin Pharma, Inc. | 10 | $171 |
| Amgen | 9 | $136 |
| GSK | 8 | $126 |
| Boehringer Ingelheim | 7 | $108 |
| Lilly USA, LLC | 7 | $85 |
| Novartis | 5 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Exact Sciences | 3 | $51 |
| Astellas Pharma US Inc | 4 | $48 |
| Corium, LLC | 2 | $40 |
| Bausch Health US, LLC | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $31 |
| Optinose US, Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Corcept Therapeutics | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Biogen | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $11 |
How this compares
$3,199 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 104 | $92,241 |
| JardianceEmpagliflozin | 60 | $82,267 |
| TrulicityDulaglutide | 50 | $73,881 |
| OzempicSemaglutide | 46 | $59,814 |
| MounjaroTirzepatide | 28 | $32,725 |
| JanuviaSitagliptin Phosphate | 19 | $23,715 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $10,166 |
| MyrbetriqMirabegron | 17 | $10,026 |
| Atorvastatin Calcium | 564 | $6,689 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,603 |
| Levothyroxine Sodium | 534 | $5,484 |
| Omeprazole | 290 | $4,542 |
| AzstarysSerdexmethylphen/Dexmethylphen | 11 | $4,385 |
| Metoprolol Succinate | 195 | $3,780 |
| Losartan Potassium | 230 | $2,867 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $85 | $106,60678 claims |
| PfizerEliquis | $671 | $92,241104 claims |
| Boehringer IngelheimJardiance | $108 | $82,26760 claims |
| Novo NordiskOzempic | $305 | $59,81446 claims |
| GSKBreo Ellipta, Anoro Ellipta | $126 | $15,76927 claims |
| Astellas Pharma US IncMyrbetriq | $48 | $10,02617 claims |
| Corium, LLCAzstarys | $40 | $4,38511 claims |
| AbbVieSynthroid | $541 | $1,35044 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Sylvania
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.